Disopyramide, procainamide, and quinidine are considered third-line agents in this situation.

这些情况下，双异丙吡胺、普鲁卡因胺丁可为三。

The clinician may consider disopyramide, procainamide, or quinidine on an individual basis.

临床医师基于个体化考虑可能会选用双异丙吡胺、普鲁卡因胺或丁。